Gonadorelin Analogues
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £406K-£423K
- Sector
- HEALTH
- Published
- 17 Jan 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Scotland:
1 buyer
- NHS National Services Scotland NSS Edinburgh
2 suppliers
Description
Supply of Gonadorelin Analogues to NHS Scotland.
Lot Division
| 1 | NP90219b Leuprorelin (Prostap®) The supply of Leuprorelin (Prostap®) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework agreement to one (1) Framework Participant. |
| 2 | NP90219c Triptorelin (Decapeptyl®) The supply of Triptorelin (Decapeptyl®) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework agreement to one (1) Framework Participant. |
Award Detail
| 1 | Takeda (London)
|
| 2 | Ipsen (Slough)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) of the Framework Agreement referred to in Section V.2.4 comprising two (2) lots cover the twelve (12) month duration of the proposed modification period of the Framework Agreement. (SC Ref:755510)
Reference
- ocds-h6vhtk-041700
- FTS 001623-2024